Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor

Some patients treated with dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) can still exhibit heightened residual platelet reactivity (HRPR), which is potentially linked to adverse vascular outcomes. Better tailored DAPT strategies are needed to address this medical need. Aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lomakin, Nikita, Rudakova, Anna, Buryachkovskaya, Liudmila, Serebruany, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Cardiovascular Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950204/
https://www.ncbi.nlm.nih.gov/pubmed/31933687
http://dx.doi.org/10.15420/ecr.2018.29.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950204/
https://www.ncbi.nlm.nih.gov/pubmed/31933687
http://dx.doi.org/10.15420/ecr.2018.29.2

Ejemplares similares